Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss — HBSS

by

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Source: globenewswire

Country: United States